PARI IN THE AMERICAS

Designed with our patients in mind, PARI products aim to provide efficient aerosol delivery and a better quality of life. PARI’s foundation is our strong clinical track record developed from years of clinical research and proven safety and efficacy with well-known nebulized medications. PARI reusable nebulizers were used in the following pivotal trials to prove safety and efficacy:

Pulmicort Respules^® - AstraZeneca
TOBI^®, Yupelri^®, Perforomist^®, Accuneb^®, and Duoneb^® - Mylan
Pulmozyme^® - Genentech
Xopenex^® and Brovana^® - Sunovion

*All registered marks and trademarks belong to their respective companies